中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(6): 1248-1254

Exercise intervention prescription for postmenopausal women with nonalcoholic fatty liver disease and related comorbidities

DOI: 10.12449/JCH240627

  • School of Physical Education，Shanghai University of Sport，Shanghai 200438，China

Research funding:

The National Social Science Fund of China (22BTY076)

More Information
  • Corresponding author: LIU Peng， liupeng@sus.edu.cn （ORCID： 0009-0002-3984-3366）
  • Received Date: 2024-03-11
  • Accepted Date: 2024-04-19
  • Published Date: 2024-06-25
    Abstract
  • The prevalence rate of nonalcoholic fatty liver disease （NAFLD） in postmenopausal women is significantly higher than that in premenopausal women and even exceeds that in men of the same age group， and exercise intervention remains an effective method for the prevention and treatment of NAFLD in postmenopausal women. In addition， postmenopausal women with NAFLD often have comorbidities such as sarcopenia， osteoporosis， cardiovascular diseases， and diabetes， which requires targeted exercise prescriptions and proactive intervention for potential comorbidities. Through a literature review， this article provides targeted recommendations for exercise intervention prescriptions in postmenopausal women with NAFLD and related comorbidities.

     

    • FullText(HTML)
  • loading
    • References(62)
  • [1]
    RINELLA ME, NEUSCHWANDER-TETRI BA, SIDDIQUI MS, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease[J]. Hepatology, 2023, 77( 5): 1797- 1835. DOI: 10.1097/HEP.0000000000000323.
    [2]
    YANG RX, FAN JG. A new understanding of nonalcoholic fatty liver disease and its rename[J]. J Clin Hepatol, 2023, 39( 8): 1775- 1779. DOI: 10.3969/j.issn.1001-5256.2023.08.002.

    杨蕊旭, 范建高. 非酒精性脂肪性肝病新认识与再更名[J]. 临床肝胆病杂志, 2023, 39( 8): 1775- 1779. DOI: 10.3969/j.issn.1001-5256.2023.08.002.
    [3]
    XUE R, YANG RX, FAN JG. Epidemiological trends and clinical characteristic of NAFLD/MAFLD in Asia[J]. J Dig Dis, 2022, 23( 7): 354- 357. DOI: 10.1111/1751-2980.13117.
    [4]
    RIAZI K, AZHARI H, CHARETTE JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7( 9): 851- 861. DOI: 10.1016/S2468-1253(22)00165-0.
    [5]
    GUTIERREZ-GROBE Y, PONCIANO-RODRÍGUEZ G, RAMOS MH, et al. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens[J]. Ann Hepatol, 2010, 9( 4): 402- 409.
    [6]
    SUZUKI A, ABDELMALEK MF. Nonalcoholic fatty liver disease in women[J]. Womens Health(Lond), 2009, 5( 2): 191- 203. DOI: 10.2217/17455057.5.2.191.
    [7]
    YANG JD, ABDELMALEK MF, PANG H, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis[J]. Hepatology, 2014, 59( 4): 1406- 1414. DOI: 10.1002/hep.26761.
    [8]
    DUNCAN RE, AHMADIAN M, JAWORSKI K, et al. Regulation of lipolysis in adipocytes[J]. Annu Rev Nutr, 2007, 27: 79- 101. DOI: 10.1146/annurev.nutr.27.061406.093734.
    [9]
    LIU PJ, LOU HP, ZHU YN. Identification of hepatic steatosis in premenopausal and postmenopausal women based on phenotypes combining triglyceride levels and anthropometric indices: A cross-sectional study[J]. Diabetes Metab Syndr Obes, 2021, 14: 1339- 1347. DOI: 10.2147/DMSO.S302297.
    [10]
    MOTA AH, WILTGEN D, GATELLI LE, et al. Cardiac abnormalities in patients with nonalcoholic fatty liver disease[J]. Rev Assoc Med Bras(1992), 2022, 68( 10): 1394- 1399. DOI: 10.1590/1806-9282.20220263.
    [11]
    POLYZOS SA, KECHAGIAS S, TSOCHATZIS EA. Review article: Non-alcoholic fatty liver disease and cardiovascular diseases: Associations and treatment considerations[J]. Aliment Pharmacol Ther, 2021, 54( 8): 1013- 1025. DOI: 10.1111/apt.16575.
    [12]
    CLARK JM, BRANCATI FL, DIEHL AM. Nonalcoholic fatty liver disease[J]. Gastroenterology, 2002, 122( 6): 1649- 1657. DOI: 10.1053/gast.2002.33573.
    [13]
    COLDITZ GA. Estrogen, estrogen plus progestin therapy, and risk of breast cancer[J]. Clin Cancer Res, 2005, 11( 2 Pt 2): 909s- 917s.
    [14]
    ROSSOUW JE, ANDERSON GL, PRENTICE RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial[J]. JAMA, 2002, 288( 3): 321- 333. DOI: 10.1001/jama.288.3.321.
    [15]
    MOLINA-MOLINA E, FURTADO GE, JONES JG, et al. The advantages of physical exercise as a preventive strategy against NAFLD in postmenopausal women[J]. Eur J Clin Invest, 2022, 52( 3): e13731. DOI: 10.1111/eci.13731.
    [16]
    CHURCH TS, EARNEST CP, SKINNER JS, et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: A randomized controlled trial[J]. JAMA, 2007, 297( 19): 2081- 2091. DOI: 10.1001/jama.297.19.2081.
    [17]
    FOSTER-SCHUBERT KE, ALFANO CM, DUGGAN CR, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women[J]. Obesity(Silver Spring), 2012, 20( 8): 1628- 1638. DOI: 10.1038/oby.2011.76.
    [18]
    FRANK LL, SORENSEN BE, YASUI Y, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: A randomized clinical trial[J]. Obes Res, 2005, 13( 3): 615- 625. DOI: 10.1038/oby.2005.66.
    [19]
    IRVING BA, DAVIS CK, BROCK DW, et al. Effect of exercise training intensity on abdominal visceral fat and body composition[J]. Med Sci Sports Exerc, 2008, 40( 11): 1863- 1872. DOI: 10.1249/MSS.0b013e3181801d40.
    [20]
    IRWIN ML, YASUI Y, ULRICH CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: A randomized controlled trial[J]. JAMA, 2003, 289( 3): 323- 330. DOI: 10.1001/jama.289.3.323.
    [21]
    NICKLAS BJ, WANG XW, YOU TJ, et al. Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: A randomized, controlled trial[J]. Am J Clin Nutr, 2009, 89( 4): 1043- 1052. DOI: 10.3945/ajcn.2008.26938.
    [22]
    NUNES PRP, BARCELOS LC, OLIVEIRA AA, et al. Effect of resistance training on muscular strength and indicators of abdominal adiposity, metabolic risk, and inflammation in postmenopausal women: Controlled and randomized clinical trial of efficacy of training volume[J]. Age(Dordr), 2016, 38( 2): 40. DOI: 10.1007/s11357-016-9901-6.
    [23]
    ABDELBASSET WK, TANTAWY SA, KAMEL DM, et al. Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial[J]. Medicine(Baltimore), 2020, 99( 10): e19471. DOI: 10.1097/MD.0000000000019471.
    [24]
    LIU WY, LU DJ, DU XM, et al. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men: The role of gut microbiota composition: Study protocol for the AELC randomized controlled trial[J]. BMC Public Health, 2014, 14: 48. DOI: 10.1186/1471-2458-14-48.
    [25]
    REZENDE REF, DUARTE SMB, STEFANO JT, et al. Randomized clinical trial: Benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease[J]. Menopause, 2016, 23( 8): 876- 883. DOI: 10.1097/GME.0000000000000647.
    [26]
    HO SS, DHALIWAL SS, HILLS AP, et al. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial[J]. BMC Public Health, 2012, 12( 1): 704. DOI: 10.1186/1471-2458-12-704.
    [27]
    MOHANKA M, IRWIN M, HECKBERT SR, et al. Serum lipoproteins in overweight/obese postmenopausal women: A one-year exercise trial[J]. Med Sci Sports Exerc, 2006, 38( 2): 231- 239. DOI: 10.1249/01.mss.0000184584.95000.e4.
    [28]
    MEDICINE ACOS. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults[J]. Med Sci Sports Exerc, 2009, 41( 3): 687- 708. DOI: 10.1249/MSS.0b013e3181915670.
    [29]
    BAE JC, SUH S, PARK SE, et al. Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults[J]. PLoS One, 2012, 7( 10): e46819. DOI: 10.1371/journal.pone.0046819.
    [30]
    O'DONOGHUE G, BLAKE C, CUNNINGHAM C, et al. What exercise prescription is optimal to improve body composition and cardiorespiratory fitness in adults living with obesity? A network meta-analysis[J]. Obes Rev, 2021, 22( 2): e13137. DOI: 10.1111/obr.13137.
    [31]
    WULLSCHLEGER S, LOEWITH R, HALL MN. TOR signaling in growth and metabolism[J]. Cell, 2006, 124( 3): 471- 484. DOI: 10.1016/j.cell.2006.01.016.
    [32]
    ZHANG F, TIAN HN, ZHOU Y, et al. Research progress on neuromuscular and molecular biological adaptation of strength and endurance training in the same period[J]. Chin J Phys Med, 2023, 42( 4): 318- 327. DOI: 10.16038/j.1000-6710.2023.04.003.

    张锋, 田浩楠, 周越, 等. 同期力量和耐力训练的神经肌肉和分子生物学适应研究进展[J]. 中国运动医学杂志, 2023, 42( 4): 318- 327. DOI: 10.16038/j.1000-6710.2023.04.003.
    [33]
    WILSON JM, MARIN PJ, RHEA MR, et al. Concurrent training: A meta-analysis examining interference of aerobic and resistance exercises[J]. J Strength Cond Res, 2012, 26( 8): 2293- 2307. DOI: 10.1519/JSC.0b013e31823a3e2d.
    [34]
    SILLANPÄÄ E, HÄKKINEN A, NYMAN K, et al. Body composition and fitness during strength and/or endurance training in older men[J]. Med Sci Sports Exerc, 2008, 40( 5): 950- 958. DOI: 10.1249/MSS.0b013e318165c854.
    [35]
    GIBALA MJ, LITTLE JP, MACDONALD MJ, et al. Physiological adaptations to low-volume, high-intensity interval training in health and disease[J]. J Physiol, 2012, 590( 5): 1077- 1084. DOI: 10.1113/jphysiol.2011.224725.
    [36]
    SWAIN DP, FRANKLIN BA. Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise[J]. Am J Cardiol, 2006, 97( 1): 141- 147. DOI: 10.1016/j.amjcard.2005.07.130.
    [37]
    MANSON JE, HU FB, RICH-EDWARDS JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women[J]. N Engl J Med, 1999, 341( 9): 650- 658. DOI: 10.1056/nejm199908263410904.
    [38]
    IMBEAULT P, SAINT-PIERRE S, ALMÉRAS N, et al. Acute effects of exercise on energy intake and feeding behaviour[J]. Br J Nutr, 1997, 77( 4): 511- 521. DOI: 10.1079/bjn19970053.
    [39]
    YOSHIOKA M, DOUCET E, ST-PIERRE S, et al. Impact of high-intensity exercise on energy expenditure, lipid oxidation and body fatness[J]. Int J Obes Relat Metab Disord, 2001, 25( 3): 332- 339. DOI: 10.1038/sj.ijo.0801554.
    [40]
    DAUSSIN FN, ZOLL J, DUFOUR SP, et al. Effect of interval versus continuous training on cardiorespiratory and mitochondrial functions: Relationship to aerobic performance improvements in sedentary subjects[J]. Am J Physiol Regul Integr Comp Physiol, 2008, 295( 1): R264- R272. DOI: 10.1152/ajpregu.00875.2007.
    [41]
    TADAISHI M, MIURA S, KAI Y, et al. Skeletal muscle-specific expression of PGC-1α-b, an exercise-responsive isoform, increases exercise capacity and peak oxygen uptake[J]. PLoS One, 2011, 6( 12): e28290. DOI: 10.1371/journal.pone.0028290.
    [42]
    CHURCH TS, BLAIR SN, COCREHAM S, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: A randomized controlled trial[J]. JAMA, 2010, 304( 20): 2253- 2262. DOI: 10.1001/jama.2010.1710.
    [43]
    GUILLET C, BOIRIE Y. Insulin resistance: A contributing factor to age-related muscle mass loss?[J]. Diabetes Metab, 2005, 31 Spec No 2: 5S20- 5 S 26. DOI: 10.1016/s1262-3636(05)73648-x.
    [44]
    SJÖBLOM S, SUURONEN J, RIKKONEN T, et al. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia[J]. Maturitas, 2013, 75( 2): 175- 180. DOI: 10.1016/j.maturitas.2013.03.016.
    [45]
    AGOSTINI D, ZEPPA DONATI S, LUCERTINI F, et al. Muscle and bone health in postmenopausal women: Role of protein and vitamin D supplementation combined with exercise training[J]. Nutrients, 2018, 10( 8): 1103. DOI: 10.3390/nu10081103.
    [46]
    DAVIS ME, BLAKE C, PERROTTA C, et al. Impact of training modes on fitness and body composition in women with obesity: A systematic review and meta-analysis[J]. Obesity(Silver Spring), 2022, 30( 2): 300- 319. DOI: 10.1002/oby.23305.
    [47]
    ROTH SM, MARTEL GF, IVEY FM, et al. High-volume, heavy-resistance strength training and muscle damage in young and older women[J]. J Appl Physiol(1985), 2000, 88( 3): 1112- 1118. DOI: 10.1152/jappl.2000.88.3.1112.
    [48]
    ZANCHETTA MB, ABDALA R, MASSARI F, et al. Postmenopausal women with sarcopenia have higher prevalence of falls and vertebral fractures. Las mujeres postmenopáusicas con sarcopenia tienen mayor prevalencia de caídas y fracturas vertebrales[J]. Medicina(B Aires), 2021, 81( 1): 47- 53.
    [49]
    SHERRINGTON C, TIEDEMANN A, FAIRHALL N, et al. Exercise to prevent falls in older adults: An updated meta-analysis and best practice recommendations[J]. N S W Public Health Bull, 2011, 22( 3-4): 78- 83. DOI: 10.1071/NB10056.
    [50]
    POLYZOS SA, KOUNTOURAS J, MANTZOROS CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics[J]. Metabolism, 2019, 92: 82- 97. DOI: 10.1016/j.metabol.2018.11.014.
    [51]
    GIANNOPOULOU I, PLOUTZ-SNYDER LL, CARHART R, et al. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes[J]. J Clin Endocrinol Metab, 2005, 90( 3): 1511- 1518. DOI: 10.1210/jc.2004-1782.
    [52]
    RAY L, LIPTON RB, ZIMMERMAN ME, et al. Mechanisms of association between obesity and chronic pain in the elderly[J]. Pain, 2011, 152( 1): 53- 59. DOI: 10.1016/j.pain.2010.08.043.
    [53]
    ROSS R, HUDSON R, STOTZ PJ, et al. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: A randomized trial[J]. Ann Intern Med, 2015, 162( 5): 325- 334. DOI: 10.7326/M14-1189.
    [54]
    LEE PG, JACKSON EA, RICHARDSON CR. Exercise prescriptions in older adults[J]. Am Fam Physician, 2017, 95( 7): 425- 432.
    [55]
    NIEDERSEER D, WERNLY B, AIGNER E, et al. NAFLD and cardiovascular diseases: Epidemiological, mechanistic and therapeutic considerations[J]. J Clin Med, 2021, 10( 3): 467. DOI: 10.3390/jcm10030467.
    [56]
    KATZEL LI, BLEECKER ER, COLMAN EG, et al. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial[J]. JAMA, 1995, 274( 24): 1915- 1921. DOI: 10.1001/jama.1995.03530240025035.
    [57]
    GARBER CE, BLISSMER B, DESCHENES MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise[J]. Med Sci Sports Exerc, 2011, 43( 7): 1334- 1359. DOI: 10.1249/MSS.0b013e318213fefb.
    [58]
    MCAULEY PA, BEAVERS KM. Contribution of cardiorespiratory fitness to the obesity paradox[J]. Prog Cardiovasc Dis, 2014, 56( 4): 434- 440. DOI: 10.1016/j.pcad.2013.09.006.
    [59]
    SCHROEDER EC, FRANKE WD, SHARP RL, et al. Comparative effectiveness of aerobic, resistance, and combined training on cardiovascular disease risk factors: A randomized controlled trial[J]. PLoS One, 2019, 14( 1): e0210292. DOI: 10.1371/journal.pone.0210292.
    [60]
    MORA-RODRIGUEZ R, FERNANDEZ-ELIAS VE, MORALES-PALOMO F, et al. Aerobic interval training reduces vascular resistances during submaximal exercise in obese metabolic syndrome individuals[J]. Eur J Appl Physiol, 2017, 117( 10): 2065- 2073. DOI: 10.1007/s00421-017-3697-7.
    [61]
    GEORGE ES, GEORGOUSOPOULOU EN, MELLOR DD, et al. Exploring the path of Mediterranean diet, non-alcoholic fatty liver disease(NAFLD) and inflammation towards 10-year cardiovascular disease(CVD) risk: The ATTICA study 10-year follow-up(2002-2012)[J]. Nutrients, 2022, 14( 12): 2367. DOI: 10.3390/nu14122367.
    [62]
    AN P, WAN ST, LUO YT, et al. Micronutrient supplementation to reduce cardiovascular risk[J]. J Am Coll Cardiol, 2022, 80( 24): 2269- 2285. DOI: 10.1016/j.jacc.2022.09.048.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (209) PDF downloads(36) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return